Skip to main content
. 2021 Aug 20;13:716917. doi: 10.3389/fnagi.2021.716917

FIGURE 12.

FIGURE 12

Neuro2A cells were treated with MCM, ACM, triggering receptor expressed on myeloid cells 2 (TREM2) overexpression + MCM, or TREM2 overexpression + ACM, and then CCK-8 and lactate dehydrogenase (LDH) release assays were performed after 24 h. (A) CCK-8 assay indicated Neuro2A cells viability changes. (B) LDH release assay indicated Neuro2A cells toxicity changes. The data are expressed as means ± SEM from three independent experiments. *p < 0.05 versus control, Δp < 0.05 versus MCM. #p < 0.05 versus ACM.